Clinical Trials List
2014-11-06 - 2024-09-30
Phase III
Terminated7
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 楊雅雯 Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 蔡立威 Division of General Surgery
- MING-YANG WANG Division of General Surgery
- SUNG-HSIN KUO Division of Hematology & Oncology
- 張允中 Division of Radiology
- YEN-SHEN LU Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- 林季宏 Division of Hematology & Oncology
- 林柏翰 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Fang Tsai Division of General Surgery
- 邱仁輝 Division of General Surgery
- 賴亦貞 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- 金光亮 未分科
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- 張潤忠 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Hong Cheng Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- 蘇智銘 Division of General Surgery
- Tsu-Yi Chao 未分科
- Wei-Hwa Lee Division of Others -
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Liang-Chih Liu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
493 participants
